Temporarily quadrupling the dose of inhaled steroid to prevent asthma exacerbations: FAST
<strong>Background</strong> Asthma exacerbations affect the quality of life of patients with asthma and have a major effect on the overall costs of asthma care. An asthma self-management plan that advises the temporary quadrupling of inhaled corticosteroid dose may prevent asthma exacerb...
Autori principali: | McKeever, T, Mortimer, K, Bradshaw, L, Haydock, R, Pavord, I, Higgins, B, Walker, S, Wilson, A, Price, D, Thomas, M, Devereux, G, Brightling, C, Renwick, C, Parrott, S, Mitchell, E, Duley, L, Harrison, T |
---|---|
Natura: | Journal article |
Lingua: | English |
Pubblicazione: |
NIHR Journals Library
2018
|
Documenti analoghi
-
FourFold Asthma Study (FAST): a study protocol for a randomised controlled trial evaluating the clinical cost-effectiveness of temporarily quadrupling the dose of inhaled steroid to prevent asthma exacerbations.
di: Skeggs, A, et al.
Pubblicazione: (2016) -
Quadrupling inhaled glucocorticoid dose to abort asthma exacerbations
di: McKeever, T, et al.
Pubblicazione: (2018) -
Can a self-management plan, which includes a four-fold increase in inhaled corticosteroid dose, reduce severe asthma exacerbations: a randomised, pragmatic trial
di: Mckeever, T, et al.
Pubblicazione: (2017) -
Pharmacokinetic optimisation of inhaled steroid therapy in asthma.
di: Pavord, I, et al.
Pubblicazione: (1993) -
Inhaled glucocorticoids and COPD exacerbations.
di: Brightling, C, et al.
Pubblicazione: (2015)